Theravance Biopharma Inc - Company Profile
Powered by 
All the sales intelligence you need on Theravance Biopharma Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Theravance Biopharma Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Theravance Biopharma Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Theravance Biopharma Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| WO2023230236A1 | Application | Process for preparing jak inhibitors and intermediates thereof | C07D471/04 | November 30, 2023 |
| US20230372318A1 | Application | Methods for treating a subject having multiple system atrophy | A61K31/451; A61P9/02 | November 23, 2023 |
| JP7383696B2 | Grant | Ｊａｋ阻害剤としての５員～７員の複素環アミド | C07D519/00; C07D487/04; A61K9/0073; A61P11/06; C07D471/04; A61P11/00; A61K31/4985; A61K31/551; A61K31/496 | November 20, 2023 |
| US11814377B2 | Grant | Pyrimidine compound as jak kinase inhibitor | A61K31/506; A61K45/06; A61K9/0014; A61K9/06; A61P17/00; A61P17/14; A61P37/06; C07B2200/13; C07D403/12; C07D451/04; C07D451/14 | November 14, 2023 |
| WO2023215478A1 | Application | Nezulcitinib for delivery by nebulized oral inhalation | A61K31/397; A61K31/416; A61K31/437; A61K47/12; A61K9/0078; A61P1/06; A61P11/00; A61P31/00; A61P31/14; A61P37/06 | November 09, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer